One of the best reasons to invest in Pfizer (NYSE: PFE) stock right now is for its dividend, which yields a mouth-watering rate of 6.7%.
That’s considerably higher than the lowly S&P 500 average of just 1.1%
To put that in terms of dollars, a $25,000 investment in Pfizer stock could generate nearly $1,700 in annual dividend income (versus less than $300 if you went with the average S&P 500 stock). Thus, the incentive for income investors to buy Pfizer stock is high. But others will argue that so too is the risk.
And those fears may be heightened after the company posted its most recent earnings numbers, with net income falling from the previous year. Is Pfizer’s dividend in danger, or does this still look like a compelling income investment? Pfizer’s earnings fell by 9% last quarter Earlier this month, Pfizer released its first-quarter 2026 results.